• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions
  • Perceived hypoglycemia- and weight-related Quality of Life of patients with sulfonylurea derivate-treated Diabetes Mellitus Type 2, a non-interventional study.

Disease
diabetes type 2
Drug Name
non drug study (cardiovascular)
Generic Name
No Drug
Sponsor
AstraZeneca
Drug Status
Non-Drug
Phase
Non-Interventional Study
Start Date
Dec 3, 2010
Study Name
NIS-CNL-DUM-2010/1
Study Id
NIS-CNL-DUM-2010/1
ClinicalTrials.gov ID
NCT01244646
Recruiting Status
Closed
Protocol Status
Not Available
Report
Dec 1, 2012
  • NIS-CNL-DUM-2010/1.pdf (132 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013